Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Bart De Taeye"'
Publikováno v:
Current Opinion in Pharmacology. 5:149-154
A classical perspective of cardiovascular risk does not adequately account for all of the cardiovascular events associated with obesity and diabetes. The combination of hypertriglyceridemia, glucose intolerance and inflammation is linked with increas
Publikováno v:
Journal of Biological Chemistry. 278:23899-23905
The serpin plasminogen activator inhibitor-1 (PAI-1) plays an important role in the regulation of the fibrinolytic activity in blood. In plasma, PAI-1 circulates mainly in the active conformation. However, PAI-1 spontaneously converts to a latent con
Autor:
Naima Moustaid-Moussa, Jung Han Kim, Nishan S. Kalupahana, Sarah Fletcher, Annie Quignard-Boulangé, Arnold M. Saxton, Brynn H. Voy, Morvarid Soltani-Bejnood, David H. Wasserman, Bart De Taeye
Publikováno v:
Frontiers in Endocrinology, Vol 3 (2013)
Frontiers in Endocrinology
Frontiers in Endocrinology, Frontiers, 2013, 3, pp.166. ⟨10.3389/fendo.2012.00166⟩
Frontiers in Endocrinology
Frontiers in Endocrinology, Frontiers, 2013, 3, pp.166. ⟨10.3389/fendo.2012.00166⟩
Numerous animal and clinical investigations have pointed to a potential role of the renin-angiotensin system (RAS) in the development of insulin resistance and diabetes in conditions of expanded fat mass. However, the mechanisms underlying this assoc
Publikováno v:
Methods in enzymology. 499
Plasminogen activator inhibitor-1 (PAI-1) is the main inhibitor of tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA) and therefore plays an important role in the plasminogen/plasmin system. PAI-1 is involved in
Plasminogen activator inhibitor-1 (PAI-1) is the main inhibitor of tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA) and therefore plays an important role in the plasminogen/plasmin system. PAI-1 is involved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ec1b14c1274860723f02c997e896fba
https://doi.org/10.1016/b978-0-12-386471-0.00005-5
https://doi.org/10.1016/b978-0-12-386471-0.00005-5
Autor:
Douglas E. Vaughan, Sheila B. Murphy, Bart De Taeye, Linda A. Gleaves, Asish K. Ghosh, William S Bradham, Joseph W. Covington
Publikováno v:
Circulation. 122(12)
Background— Elevated levels of plasminogen activator inhibitor-1 (PAI-1), a potent inhibitor of urokinase plasminogen activator and tissue plasminogen activator, are implicated in the pathogenesis of tissue fibrosis. Paradoxically, lack of PAI-1 in
Autor:
Jun Yang, Sheila B. Murphy, Bruce B. Hammock, David B. Friedman, Ayala Luria, Bart De Taeye, Douglas E. Vaughan, Christophe Morisseau, Joseph W. Covington, Julie Coyle
Obesity is an increasingly important public health issue reaching epidemic proportions. Visceral obesity has been defined as an important element of the metabolic syndrome and expansion of the visceral fat mass has been shown to contribute to the dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ecd8b51c626241a34554dbfebc13986
https://europepmc.org/articles/PMC2864128/
https://europepmc.org/articles/PMC2864128/
Publikováno v:
Current drug targets. 8(9)
At present, thrombolytic agents represent the only direct way of augmenting fibrinolytic activity in humans. While these agents are proven to be efficacious in the treatment of acute thrombotic events, they are not a viable option for long-term admin
Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity
Autor:
Tatiana Novitskaya, Bart De Taeye, Douglas E. Vaughan, Owen P. McGuinness, Mousumi Medda, Joseph W. Covington, Linda A. Gleaves
Publikováno v:
American journal of physiology. Endocrinology and metabolism. 293(3)
Obesity is commonly associated with development of insulin resistance and systemic evidence of inflammation. Macrophages contribute to inflammatory amplification in obesity and may contribute directly to insulin resistance and the development of nona
Publikováno v:
The Journal of biological chemistry. 281(43)
Plasma levels of plasminogen activator inhibitor-1 (PAI-1) are elevated in obesity and correlate with body mass index. The increase in PAI-1 associated with obesity likely contributes to increased cardiovascular risk and may predict the development o